-
Published in:
Transfuze Hematol. dnes,27, 2021, No. Supplementum 2, p. 1-144.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
- Minimum and Optimal Factor Levels in Physically Active Hemophiliacs
Most read in this issue